What explains the big percentage move in QBIO stock today?

The large percent move reflects extremely low prior price and thin liquidity. A move from **USD 0.00001** to **USD 0.00010** yields large percentage gains. Microcap trading flows and any positive company update can amplify moves.

What is Meyka AI's rating for QBIO stock and what does it mean?

Meyka AI rates QBIO **67.25/100, grade B, suggestion HOLD**. The grade accounts for benchmark, sector, financial growth, key metrics, forecasts and analyst signals. This is informational, not investment advice.

What price targets does the Meyka model show for QBIO stock?

Meyka AI's forecast model projects a base case **USD 0.00100** (+**900.00%**) and a bullish case **USD 0.00500** (+**4,900.00%**) versus the current **USD 0.00010**. Forecasts are model-based projections and not guarantees.

How liquid is QBIO stock for trading?

Liquidity is low: today’s volume **5,700** vs average volume **4,228**. Low price and small floats mean wide spreads and execution risk for larger orders.

US Stocks

QBIO Q BioMed (PNK) rises to $0.00010 on 21 Mar 2026: watch catalyst-driven momentum

ByHuzaifa Zahoor March 21, 2026March 21, 2026

We saw QBIO stock move sharply during market hours on 21 Mar 2026, trading at USD 0.00010 on the PNK exchange as volume ticked to 5,700 shares. The move follows small-cap biotech flows into speculative names in the Healthcare sector and a jump from a prior close of USD 0.00001, implying a intraday change near 9,900.00%. We flag the price action and note liquidity, market cap of USD 14,509, and the company pipeline as immediate context for traders and investors monitoring short-term momentum.